Chai Discovery

San Francisco, CA, USA
Founded 2024

Chai Discovery develops AI models for molecular structure prediction in drug discovery. Their platform uses advanced AI to predict the structure of biochemical molecules, including proteins, small molecules, DNA, RNA, and covalent modifications. This technology helps researchers design new medications by providing unified molecular predictions without requiring multiple sequence alignments.

Last Updated: August 6, 2025

Current Valuation

$550M

as of August 6, 2025 (Source)

Funding Summary

$130M

Total reported funding

Key People

Danny Geisz
Founding AI ScientistFounder
LinkedIn Profile
Zhuoran Qiao
Founding AI ScientistFounder
LinkedIn Profile
Kevin Wu
Founding AI ScientistFounder
LinkedIn Profile

Core OSS Projects

Chai-1 is a multi-modal foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of benchmarks. Chai-1 enables unified prediction of proteins, small molecules, DNA, RNA, glycosylations, and more.

License: Apache 2.0

Chai-1 is a multi-modal foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of benchmarks. Chai-1 enables unified prediction of proteins, small molecules, DNA, RNA, glycosylations, and more.

License: Apache 2.0

Business Information

Industries

Health Care & Life SciencesResearch & Academia

Technologies

Biotech
AI/ML
Pharmatech

Sectors

Enterprise

Licenses

Apache-2.0

Cossmology Badge

Showcase your company's presence on Cossmology by embedding a custom badge on your website or GitHub repository.

COSS Weekly Newsletter

Stay up to date with the latest news, funding rounds, and announcements from the COSS universe.

Check out COSS Weekly on the web

All information submitted through this form is handled in accordance with the Privacy Policy of Chinstrap Community.